Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Table of Contents

December 2022; Volume 42,Issue 12

Review

  • You have access
    Phase I CAR-T Clinical Trials Review
    SHAUN BULSARA, MENGFEN WU and TAO WANG
    Anticancer Research December 2022, 42 (12) 5673-5684; DOI: https://doi.org/10.21873/anticanres.16076

Experimental Studies

  • Open Access
    In Vitro Anticancer Activity of the Light Stable Zinc Isotope (64Zn) Compounds
    PETER NOVAK, ALEXANDR BALAKIN and MAX TEMNIK
    Anticancer Research December 2022, 42 (12) 5685-5698; DOI: https://doi.org/10.21873/anticanres.16077
  • Open Access
    The Prognostic Value of Plasma Small Extracellular Vesicles’ Phenotype in Patients With Gastrointestinal Stromal Tumor
    CHARLOTTE M. BRINCH, ESTRID HOGDALL, PIETER DE HEER, LUIT PENNINGA, RIKKE BÆK, MALENE M. JORGENSEN, BODIL E. ENGELMANN, PHILIP B. ROSSEN, HELENE J. MORTENSEN, ANDERS KRARUP-HANSEN and NINNA AGGERHOLM-PEDERSEN
    Anticancer Research December 2022, 42 (12) 5699-5717; DOI: https://doi.org/10.21873/anticanres.16078
  • Open Access
    GPX4 Regulates Tumor Cell Proliferation via Suppressing Ferroptosis and Exhibits Prognostic Significance in Gastric Cancer
    KEN SUGEZAWA, MASAKI MORIMOTO, MANABU YAMAMOTO, YOSHIAKI MATSUMI, YUJI NAKAYAMA, KAZUSHI HARA, CHIHIRO UEJIMA, KYOICHI KIHARA, TOMOYUKI MATSUNAGA, NARUO TOKUYASU, TERUHISA SAKAMOTO, YOSHIHISA UMEKITA and YOSHIYUKI FUJIWARA
    Anticancer Research December 2022, 42 (12) 5719-5729; DOI: https://doi.org/10.21873/anticanres.16079
  • Open Access
    The Expression of Histone Acetyltransferase KAT6A in Non-small Cell Lung Cancer
    ALEKSANDRA PARTYNSKA, ALEKSANDRA PIOTROWSKA, KONRAD PAWELCZYK, ADAM RZECHONEK, KATARZYNA RATAJCZAK-WIELGOMAS, MARZENNA PODHORSKA-OKOLOW and PIOTR DZIEGIEL
    Anticancer Research December 2022, 42 (12) 5731-5741; DOI: https://doi.org/10.21873/anticanres.16080
  • You have access
    Intracellular C3 Modulates EMT via the Akt/Smad Pathway in Pancreatic Cancer Cells
    REI SUZUKI, TADAYUKI TAKAGI, MITSURU SUGIMOTO, YUKI SATO, HIROKI IRIE, YUKI YOMOGIDA and HIROMASA OHIRA
    Anticancer Research December 2022, 42 (12) 5743-5750; DOI: https://doi.org/10.21873/anticanres.16081
  • You have access
    Immunohistochemical Analysis of Common Cancer Antigens in Head and Neck Squamous Cell Carcinoma
    YOHEI MORISHITA, KAZUMASA TAKENOUCHI, SHINGO SAKASHITA, KAZUTO MATSUURA, RYUICHI HAYASHI and TETSUYA NAKATSURA
    Anticancer Research December 2022, 42 (12) 5751-5761; DOI: https://doi.org/10.21873/anticanres.16082
  • You have access
    Endosomal Localization of RacGAP Protein ARHGAP22 Regulates its GAP Activity in Human Melanoma Cells
    MAMIKO MORI, KOJI SAITO, AYANO SEKINE, RIO HASEBE and YASUTAKA OHTA
    Anticancer Research December 2022, 42 (12) 5763-5771; DOI: https://doi.org/10.21873/anticanres.16083
  • Open Access
    COX-2 Acts as a Key Mediator of Trifluoperazine-induced Cell Death in U87MG Glioma Cells
    JUYEONG PARK, JOO YEON JEONG and SANG SOO KANG
    Anticancer Research December 2022, 42 (12) 5773-5781; DOI: https://doi.org/10.21873/anticanres.16084
  • You have access
    Chronological Change in EPHA2 Protein Expression Is Associated With Recurrence of Bladder Cancer
    MITSUYUKI KOIZUMI, SHINYA SATO, MITSUYO YOSHIHARA, YOSHIYASU NAKAMURA, HIDEYUKI TERAO, YOICHIRO OKUBO, KOTA WASHIMI, EMI YOSHIOKA, TOMOYUKI YOKOSE, TAKESHI KISHIDA, NAOHIKO KOSHIKAWA and YOHEI MIYAGI
    Anticancer Research December 2022, 42 (12) 5783-5794; DOI: https://doi.org/10.21873/anticanres.16085
  • You have access
    Genetic Predisposition to Male Breast Cancer: A Case Series
    ANGELA APESSOS, KONSTANTINOS AGIANNITOPOULOS, GEORGIA PEPE, GEORGIOS N. TSAOUSIS, PANAGIOTA PITTA, CHRYSANTHI BILI, LINA FLORENTIN, EMMANOUEL SALOUSTROS, ELEFTHERIOS KAMPLETSAS, DIMITRIOS TRYFONOPOULOS, NIKOLAOS TSOUKALAS, EVANGELOS BOURNAKIS, FLORA ZAGOURI, ATHANASSIOS KOTSAKIS, ANNA KOUMARIANOU, IPPOKRATIS KORANTZIS, IOANNIS BOUKOVINAS, GEORGE LYPAS, GEORGIOS FOUNTZILAS, VASILIKI MICHALAKI, SPYRIDON XYNOGALOS, HELENA LINARDOU, EIRINI PAPADOPOULOU, GEORGE NASIOULAS and VASSILIS GEORGOULIAS
    Anticancer Research December 2022, 42 (12) 5795-5801; DOI: https://doi.org/10.21873/anticanres.16086
  • You have access
    Hypoxia Increases the Proliferative and Metastatic Ability of Canine Mammary Tumor Cells via Up-regulation of TSG-6
    TAE-HYEON KIM, JEONG-HWA LEE, JU-HYUN AN, BYUNG-GEE KO, KYEONG-BO KIM and HWA-YOUNG YOUN
    Anticancer Research December 2022, 42 (12) 5803-5812; DOI: https://doi.org/10.21873/anticanres.16087

Clinical Studies

  • Open Access
    Disparities in Time to Treatment for Breast Cancer
    KULKAEW SUKNIAM, ALI ABBASZADEH KASBI, MOHAMMED ALI ASHARY, KYLE POPP, KRISTOPHER ATTWOOD, ANTHONY GEORGE and EMMANUEL GABRIEL
    Anticancer Research December 2022, 42 (12) 5813-5818; DOI: https://doi.org/10.21873/anticanres.16088
  • Open Access
    Elimination of Axillary-Lymph-Node Metastases in a Patient With Invasive Lobular Breast Cancer Treated by First-line Neo-adjuvant Chemotherapy Combined With Methionine Restriction
    YUTARO KUBOTA, QINGHONG HAN, NORIYUKI MASAKI, CHIHIRO HOZUMI, KAZUYUKI HAMADA, YUSUKE AOKI, KOYA OBARA, TAKUYA TSUNODA and ROBERT M. HOFFMAN
    Anticancer Research December 2022, 42 (12) 5819-5823; DOI: https://doi.org/10.21873/anticanres.16089
  • Open Access
    Autologous and Allogeneic Stem Cell Transplantation as Salvage Treatment Options for Relapsed/Refractory Multiple Myeloma: A Single-center Experience over 20 Years
    NORMANN STEINER, PAULA SCHOBER, WOLFGANG WILLENBACHER, BRIGITTE KIRCHER, EBERHARD GUNSILIUS, DOMINIK WOLF and DAVID NACHBAUR
    Anticancer Research December 2022, 42 (12) 5825-5832; DOI: https://doi.org/10.21873/anticanres.16090
  • Open Access
    Significance of Zinc Replacement Therapy After Pancreaticoduodenectomy
    CHIE TAKISHITA, YUICHI NAGAKAWA, HIROAKI OSAKABE, NOBUHIKO NAKAGAWA, YUSUKE MITSUKA, JUNICHI MAZAKI, KENICHI IWASAKI, TETSUO ISHIZAKI and SHINGO KOZONO
    Anticancer Research December 2022, 42 (12) 5833-5837; DOI: https://doi.org/10.21873/anticanres.16091
  • You have access
    Evaluation of the Diagnostic Potential of Circulating MicroRNAs miR-1 and miR-21 in Patients With Ovarian Cancer
    DAMIAN J. RALSER, MATEJA CONDIC, EVA EGGER, DOMINIQUE KOENSGEN, ALEXANDER MUSTEA and MATTHIAS B. STOPE
    Anticancer Research December 2022, 42 (12) 5839-5845; DOI: https://doi.org/10.21873/anticanres.16092
  • You have access
    Efficacy of Chemotherapy Plus Bevacizumab in Recurrent Glioblastoma Multiform: A Real-life Study
    ALEXANDRE BEIGE, FRANÇOIS GHIRINGHELLI, JULIE LECUELLE, CAROLINE TRUNTZER, GILLES TRUC, JULIE VINCENT, WALID FARAH, FRANÇOIS BORSOTTI, IRINA MAZILU and SILVIA MIHAELA ILIE
    Anticancer Research December 2022, 42 (12) 5847-5858; DOI: https://doi.org/10.21873/anticanres.16093
  • You have access
    Predicting Overall Survival Using Machine Learning Algorithms in Oral Cavity Squamous Cell Carcinoma
    JIA YAN TAN, JOHN ADEOYE, PETER THOMSON, DILEEP SHARMA, POORNIMA RAMAMURTHY and SIU-WAI CHOI
    Anticancer Research December 2022, 42 (12) 5859-5866; DOI: https://doi.org/10.21873/anticanres.16094
  • You have access
    Detection of “Incidentalomas” on Brain and Body 68Ga-DOTATOC-PET Scans: A Retrospective Study and Case Illustration
    GIUSEPPE EMMANUELE UMANA, GIANLUCA FERINI, MANDARA MURALIDHAR HARIKAR, TEJAS VENKATARAM, ROBERTA COSTANZO, GIANLUCA SCALIA, PAOLO PALMISCIANO, LARA BRUNASSO, FEDERICA PAOLINI, ANDREA SCIORTINO, ROSARIO MAUGERI, ANTONIO CREA, FABIO BARONE, FRANCESCO INSERRA, VALERIO DA ROS, GIACOMO CUTTONE, GABRIELE CORSALE, CONCETTO CRISTAUDO, SEBASTIANO COSENTINO, MARIA GABRIELLA SABINI and MASSIMO IPPOLITO
    Anticancer Research December 2022, 42 (12) 5867-5873; DOI: https://doi.org/10.21873/anticanres.16095
  • Open Access
    A Machine Learning Approach Using PET/CT-based Radiomics for Prediction of PD-L1 Expression in Non-small Cell Lung Cancer
    CHAE HONG LIM, YOUNG WHA KOH, SEUNG HYUP HYUN and SU JIN LEE
    Anticancer Research December 2022, 42 (12) 5875-5884; DOI: https://doi.org/10.21873/anticanres.16096
  • You have access
    Clinical Significance of SEC11A Expression in Patients With Locally Advanced Gastric Cancer
    HIDEAKI SUEMATSU, KENTARO SAKAMAKI, NAOHIDE OUE, YUKIHIKO HIROSHIMA, YAYOI KIMURA, SHIZUNE ONUMA, ITARU HASHIMOTO, SHINSUKE NAGASAWA, TORU AOYAMA, TAKANOBU YAMADA, HIROSHI TAMAGAWA, TAKASHI OGATA, YASUSHI RINO, MUNETAKA MASUDA, WATARU YASUI, YOHEI MIYAGI and TAKASHI OSHIMA
    Anticancer Research December 2022, 42 (12) 5885-5890; DOI: https://doi.org/10.21873/anticanres.16097
  • Open Access
    Further Study on Field Cancerization in the Human Colon
    CARLOS A. RUBIO, CORINNA LANG-SCHWARZ and MICHAEL VIETH
    Anticancer Research December 2022, 42 (12) 5891-5895; DOI: https://doi.org/10.21873/anticanres.16098
  • You have access
    Fibroblast Activation Protein and Tertiary Lymphoid Structure in Colorectal Cancer Recurrence
    SHIMON HAYASE, NORIKATSU MIYOSHI, SHIKI FUJINO, MASAYOSHI YASUI, MASAYUKI OHUE, SOICHIRO MINAMI, SHINYA KATO, AYUMI NAGAE, YUKI SEKIDO, TSUYOSHI HATA, ATSUSHI HAMABE, TAKAYUKI OGINO, HIDEKAZU TAKAHASHI, MAMORU UEMURA, HIROFUMI YAMAMOTO, YUICHIRO DOKI and HIDETOSHI EGUCHI
    Anticancer Research December 2022, 42 (12) 5897-5907; DOI: https://doi.org/10.21873/anticanres.16099
  • You have access
    Simultaneously Integrated Boost Affects Survival in Locally Advanced p16-Negative Oropharyngeal Squamous Cell Carcinoma
    FRANCESCA DE FELICE, DANIELA MUSIO, MARIA SERPONE, GIANMARCO VAVALLE, CLAUDIA MARCHETTI and VINCENZO TOMBOLINI
    Anticancer Research December 2022, 42 (12) 5909-5915; DOI: https://doi.org/10.21873/anticanres.16100
  • You have access
    Evaluation of Lung Toxicity With Lenalidomide Using the Pharmacovigilance Database
    JUNYA SATO, TSUCHIYA EREN, SAEKO MURATA, TADASHI SHIMIZU and MAYAKO UCHIDA
    Anticancer Research December 2022, 42 (12) 5917-5925; DOI: https://doi.org/10.21873/anticanres.16101
  • You have access
    Low Expression of SNAI1 in Lymph Node Metastasis Indicates Delayed Recurrence of Colonic Cancer
    SUKCHOL LIM, KAZUSHIGE KAWAI, HIROAKI NOZAWA, KAZUHITO SASAKI, KOJI MURONO, SHIGENOBU EMOTO, YUICHIRO YOKOYAMA, HIROYUKI MATSUZAKI, YUZO NAGAI, SHINYA ABE, YUICHIRO YOSHIOKA, TAKAHIDE SHINAGAWA, HIROFUMI SONODA and SOICHIRO ISHIHARA
    Anticancer Research December 2022, 42 (12) 5927-5935; DOI: https://doi.org/10.21873/anticanres.16102
  • You have access
    Limited Oncological Benefits of Laparoscopic Total Gastrectomy With Splenectomy for Patients With Type 4 or Large Type 3 Gastric Cancer
    MASAZUMI SAKAGUCHI, HISAHIRO HOSOGI, SHIGEO HISAMORI, YOSUKE KINJO, SEIICHIRO KANAYA and KAZUTAKA OBAMA
    Anticancer Research December 2022, 42 (12) 5937-5944; DOI: https://doi.org/10.21873/anticanres.16103
  • You have access
    Effect of Secondary Prophylactic G-CSF on the Occurrence of Febrile Neutropenia in Breast Cancer
    KANAKO SUZUKI, SHINSUKE SASADA, YURI KIMURA, AKIKO EMI, TAKAYUKI KADOYA and MORIHITO OKADA
    Anticancer Research December 2022, 42 (12) 5945-5949; DOI: https://doi.org/10.21873/anticanres.16104
  • You have access
    Clinical Outcome and Risk Factors of Chronic Radiation Proctitis Following Pelvic Radiation Therapy
    CHAN-MUK IM, ICK-JOON CHO, HYUNG-JOO YU, BORA HAN, HYUNG-HOON OH, YOON-JIN SEO, KI-HYUN KIM, DAE-SEONG MYUNG, SUNG-BOM CHO, WAN-SIK LEE, TAEK-KEUN NAM and YOUNG-EUN JOO
    Anticancer Research December 2022, 42 (12) 5951-5959; DOI: https://doi.org/10.21873/anticanres.16105
  • You have access
    Impact of Corticosteroids for IrAEs on the Clinical Outcome of Immunotherapy in Patients With NSCLC
    KAZUHIRO SHIMOMURA, TEPPEI YAMAGUCHI, YUKO OYA, KOSAKU UCHIDA and KENTA MUROTANI
    Anticancer Research December 2022, 42 (12) 5961-5969; DOI: https://doi.org/10.21873/anticanres.16106
  • You have access
    Impact of Osteopenia on Pancreatic Fistula in Patients Undergoing Pancreaticoduodenectomy
    TAKAHIRO YAMANAKA, NORIFUMI HARIMOTO, RYO MURANUSHI, KOUKI HOSHINO, KEI HAGIWARA, NORIHIRO ISHII, MARIKO TSUKAGOSHI, AKIRA WATANABE, KENICHIRO ARAKI and KEN SHIRABE
    Anticancer Research December 2022, 42 (12) 5971-5976; DOI: https://doi.org/10.21873/anticanres.16107
  • You have access
    Detailed Surgical Techniques and Short-term Clinical Outcomes of Sleeve Lobectomy for Locally Advanced Right Lower Lobe Lung Cancer
    TAKUMA TSUKIOKA, NOBUHIRO IZUMI, HIROAKI KOMATSU, HIDETOSHI INOUE, RYUICHI ITO, SATOSHI SUZUKI and NORITOSHI NISHIYAMA
    Anticancer Research December 2022, 42 (12) 5977-5982; DOI: https://doi.org/10.21873/anticanres.16108
  • You have access
    Impact of Abdominal Aortic Calcification After Major Hepatobiliary Pancreatic Surgery: A Retrospective Cohort Study
    YUKI IMAOKA, MASAHIRO OHIRA, KOKI SATO, KOUKI IMAOKA, TOMOAKI BEKKI, RYOSUKE NAKANO, SHINTARO KURODA, HIROYUKI TAHARA, KENTARO IDE, TSUYOSHI KOBAYASHI, YUKA TANAKA and HIDEKI OHDAN
    Anticancer Research December 2022, 42 (12) 5983-5989; DOI: https://doi.org/10.21873/anticanres.16109
  • You have access
    Definitive Radiotherapy Using Electron Beam and Intensity-modulated Radiotherapy for Unresectable Angiosarcoma of the Scalp
    NAOKO OKANO, HIKARU YUMISAKI, SHINTARO SAITO, NOBUTERU KUBO, KOHEI OKADA, HIDEMASA KAWAMURA, MASAHITO YASUDA and TATSUYA OHNO
    Anticancer Research December 2022, 42 (12) 5991-5997; DOI: https://doi.org/10.21873/anticanres.16110
  • You have access
    Modified Geriatric Nutrition Risk Index as a Prognostic Predictor for Unresectable/Recurrent Esophageal Cancer
    KEITA KOUZU, HIRONORI TSUJIMOTO, NAOYUKI UEHATA, YUSUKE ISHIBASHI, YOJI KISHI and HIDEKI UENO
    Anticancer Research December 2022, 42 (12) 5999-6006; DOI: https://doi.org/10.21873/anticanres.16111
  • You have access
    Impact of Post-progression Survival on Outcomes of Lenvatinib Treatment for Unresectable Hepatocellular Carcinoma: A Systematic Review and Retrospective Cohort Study
    KAZUTO TAJIRI, YOSHIHARU TOKIMITSU, KENGO KAWAI, YUCHI MOTOFUJI, EIJI SHINNO, YOSHIRO KASHII, NOZOMU MURAISHI, AIKO MURAYAMA, YUKA HAYASHI, MASAMI MINEMURA, TERUMI TAKAHARA, YUKIHIRO SHIMIZU and ICHIRO YASUDA
    Anticancer Research December 2022, 42 (12) 6007-6018; DOI: https://doi.org/10.21873/anticanres.16112
  • You have access
    Prognostic Nutrition Index as an Indicator of Therapeutic Response to Lenvatinib Therapy in Hepatocellular Carcinoma
    MASAHITO SHIBANO, KATSUYUKI TAKAHASHI, MASAYA TAKAHASHI, SAWAKO UCHIDA-KOBAYASHI, NORIFUMI KAWADA, YASUTAKA NAKAMURA, TORU OTORI and KATSUYA NAGAYAMA
    Anticancer Research December 2022, 42 (12) 6019-6026; DOI: https://doi.org/10.21873/anticanres.16113
  • You have access
    Risk of Abemaciclib-induced Liver Injury in Hormone Receptor-positive, HER2-negative Metastatic Breast Cancer: A Retrospective Analysis
    AZUSA TANIGUCHI, NOBUYOSHI KITTAKA, HARUKA KANAOKA, SATOMI NAKAJIMA, YURI OYAMA, YUKIKO SETO, AI SOMA, HIROKI KUSAMA, NORIYUKI WATANABE, SAKI MATSUI, MINAKO NISHIO, FUMIE FUJISAWA and TAKAHIRO NAKAYAMA
    Anticancer Research December 2022, 42 (12) 6027-6035; DOI: https://doi.org/10.21873/anticanres.16114
  • You have access
    Correlation Between Tumor Uptake on FDG-PET and Malignant Features in Esophageal Squamous Cell Carcinoma After Neoadjuvant Chemotherapy Followed by Surgery
    YOICHI HAMAI, MANABU EMI, YUTA IBUKI, TOMOAKI KUROKAWA, TORU YOSHIKAWA, MANATO OHSAWA, RYOSUKE HIROHATA, NAO KITASAKI and MORIHITO OKADA
    Anticancer Research December 2022, 42 (12) 6037-6045; DOI: https://doi.org/10.21873/anticanres.16115
  • You have access
    Treatment Outcomes and Prognostic Factors of Concurrent Chemoradiotherapy With Docetaxel, Cisplatin, and Fluorouracil in Advanced Head and Neck Cancer
    TAKAHIRO KUSAKA, KIYOTO SHIGA, KATSUNORI KATAGIRI, DAISUKE SAITO, SHIN-ICHI OIKAWA, AYA IKEDA, KODAI TSUCHIDA, JUN MIYAGUCHI, YU OHASHI, HISANORI ARIGA and KOZO TANNO
    Anticancer Research December 2022, 42 (12) 6047-6056; DOI: https://doi.org/10.21873/anticanres.16116
  • You have access
    Association of ABC and RENAL Scoring Systems With Morbidity in Partial Nephrectomy
    MIGUEL E. JIMÉNEZ ROMERO, ISABEL BUENO GONZÁLEZ, MIGUEL A. SÁNCHEZ HURTADO, JOSÉ CARLOS RODRÍGUEZ BOCANEGRA and JOSÉ D. SANTOTORIBIO
    Anticancer Research December 2022, 42 (12) 6057-6062; DOI: https://doi.org/10.21873/anticanres.16117
  • You have access
    First-Line Gemcitabine, Nab-Paclitaxel, and Oxaliplatin Chemotherapy With Itraconazole in Patients With Metastatic Pancreatic Cancer: A Single Institution Experience
    MIYUKI SAWASAKI, HIROSHI TSUBAMOTO, AYAKO SUGIHARA, SHINICHI IKUTA, YOSHIYUKI SAKAI, YUKIO OSAKI and TAKASHI SONODA
    Anticancer Research December 2022, 42 (12) 6063-6069; DOI: https://doi.org/10.21873/anticanres.16118
  • You have access
    Predictive Factors of Febrile Neutropenia After Primary Prophylactic Pegfilgrastim With DCF Chemotherapy for Esophageal Cancer
    TAKAHITO INAGAKI, MIKI SATO, MASAOKI KIN, KOJI OTSUKA, MASAHIKO MURAKAMI and MARI KOGO
    Anticancer Research December 2022, 42 (12) 6071-6081; DOI: https://doi.org/10.21873/anticanres.16119
  • You have access
    Bendamustine Plus Rituximab for Mantle Cell Lymphoma: A Korean, Multicenter Retrospective Analysis
    JUN HO YI, SEOK JIN KIM, JEONG-OK LEE, GYEONG-WON LEE, JAE-YONG KWAK, HYEON-SEOK EOM, JAE-CHEOL JO, YOON SEOK CHOI, SUNG YONG OH and WON SEOG KIM
    Anticancer Research December 2022, 42 (12) 6083-6089; DOI: https://doi.org/10.21873/anticanres.16120
  • You have access
    Clinical Benefit of Bevacizumab and Irinotecan (BEV+IRI) in Patients With Relapsed/Refractory Glioblastoma (r/rGBM) and its Potential Predictors
    JI HYUN PARK, HYUN SEOK LEE, JIN WOO CHOI, SO DUG LIM, HYEON KANG KOH, KYUNG RAE CHO, JOON CHO, YOUNG-CHO KOH and SO YOUNG YOON
    Anticancer Research December 2022, 42 (12) 6091-6098; DOI: https://doi.org/10.21873/anticanres.16121
  • You have access
    Safety and Efficacy of Palliative Radiotherapy (25 Gy × 5 Fractions) for Symptomatic Pelvic Tumors
    TOMOMI AOSHIKA, TAKANORI ABE, MISAKI IINO, SATOSHI SAITO, YASUHIRO RYUNO, TOMOHIRO OHTA, MITSUNOBU IGARI, RYUTA HIRAI, YU KUMAZAKI, SHIN-EI NODA and SHINGO KATO
    Anticancer Research December 2022, 42 (12) 6099-6103; DOI: https://doi.org/10.21873/anticanres.16122
  • You have access
    A Multi-institutional Study to Diagnose the Risk of Lymph Node Metastasis Using a CRP Genetic Polymorphism Test Kit in pT1, cN0 Thoracic Esophageal Squamous Cell Carcinoma
    SATORU MOTOYAMA, MIKI HOSAKA, TAKASHI KAMEI, MASAKI UENO, MASAYUKI WATANABE, YU OHKURA, SHINJI MINE, SHUNSUKE TANABE, TAKAHIRO TOYOKAWA, AKIYUKI WAKITA, KATSUNORI NISHIKAWA, ITASU NINOMIYA, KAZUMA FUJITA, MIE KANDA, MITSUHARU HIRAI, MANAMI HOSHI, SHIH-WEI CHIU, MUNENORI TAKATA, TAKUHIRO YAMAGUCHI and MASATOMO MIURA
    Anticancer Research December 2022, 42 (12) 6105-6112; DOI: https://doi.org/10.21873/anticanres.16123
  • You have access
    Overall Survival of Small-cell Lung Cancer Patients With Malignant Central Airway Obstruction Who Received Chemotherapy Without Undergoing Transbronchial Interventions: A Single-institution Retrospective Study
    KOSUKE KASHIWABARA, SHINJI FUJII, SHINSUKE TSUMURA and KAZUHIKO SAKAMOTO
    Anticancer Research December 2022, 42 (12) 6113-6119; DOI: https://doi.org/10.21873/anticanres.16124
  • You have access
    Unusual Findings in a Patient With Carney Complex due to a Novel PRKAR1A Mutation
    REINHARD E. FRIEDRICH and MARTIN ZENKER
    Anticancer Research December 2022, 42 (12) 6121-6125; DOI: https://doi.org/10.21873/anticanres.16125
  • You have access
    Prospective Observational Study of Sorafenib in Hepatocellular Carcinoma Patients With Very High Risk of Recurrence After Surgery
    SATORU SEO, ETSURO HATANO, MASASHI KANAI, KOHEI OGAWA, YASUTSUGU TAKADA, SHOGO KOBAYASHI, HIDETOSHI EGUCHI, HIROAKI NAGANO and TATSUYA IOKA
    Anticancer Research December 2022, 42 (12) 6127-6134; DOI: https://doi.org/10.21873/anticanres.16126

Corrigenda

  • Open Access
    Corrigendum
    Anticancer Research December 2022, 42 (12) 6135;

Index

  • Open Access
    Index
    Anticancer Research December 2022, 42 (12) 6137-6308;
Back to top
PreviousNext

In this issue

Anticancer Research: 42 (12)
Anticancer Research
Vol. 42, Issue 12
December 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)

Issue highlights

  • Phase I CAR-T Clinical Trials Review
  • In Vitro Anticancer Activity of the Light Stable Zinc Isotope (64Zn) Compounds
  • The Prognostic Value of Plasma Small Extracellular Vesicles’ Phenotype in Patients With Gastrointestinal Stromal Tumor
  • GPX4 Regulates Tumor Cell Proliferation via Suppressing Ferroptosis and Exhibits Prognostic Significance in Gastric Cancer
  • Autologous and Allogeneic Stem Cell Transplantation as Salvage Treatment Options for Relapsed/Refractory Multiple Myeloma: A Single-center Experience over 20 Years
Sign up for alerts

Jump to

  • Review
  • Experimental Studies
  • Clinical Studies
  • Corrigenda
  • Index
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire